The clinical presentation of a frontal lobe neoplasm comprises various symptoms related to the tasks that the frontal lobe is responsible for - planning, organization, critical thinking, and most importantly, cognition [1] [2] [3] [4]. The term "frontal lobe syndrome" is often used to depict the signs and symptoms observed in these patients [2] [3]. Personality and mood changes are one of the most prominent findings in the setting of a frontal lobe neoplasm and manifest as uncharacteristically impulsive behavior, bouts of aggression, hypersexuality, apathy, or a combination of all [1] [3] [4] [5]. Depression, paranoia, and/or mania is commonly encountered patients with frontal lobe neoplasms [1] [2] [3] [4] [5]. Loss of memory and/or focus, withdrawal from social life, and a reduced capacity for judgment are other notable signs of frontal lobe dysfunction [3]. Some authors have established that specific symptoms arise as a result of damage to specific areas of the frontal lobe [2] [3]. Namely, behavioral and personality deficits are most likely to occur if the prefrontal cortex is damaged, whereas cognitive dysfunction is highly indicative of an ongoing process in the dorsolateral region of the frontal lobe [2] [3]. Loss of the sense of smell (anosmia) is another important sign that must include frontal lobe tumors in the differential diagnosis, particularly in the presence of behavioral or cognitive symptoms [6] [7].

The first and most important step of the diagnostic workup is a complete clinical assessment. A properly obtained patient history that determines the presence of even minor neurological deficits and a thorough physical examination that identifies these changes are sufficient to make a presumptive diagnosis. Both specific (anosmia, apraxia, and personality or cognitive deficits) and nonspecific (weight loss, improper sleep, anorexia, etc.) signs can point to an underlying process in the brain [1], providing sufficient evidence to employ imaging studies. CT and MRI are very useful for macroscopic evaluation of the brain and allow for the identification of a frontal lobe neoplasm in a short period of time [1]. A CT scan is more feasible and is accompanied by less risk for patients compared to an MRI scan, but the latter is superior in visualizing neoplastic changes, particularly in the white matter [1]. Although larger studies promote the argument against routine neuroimaging studies in the case of psychiatric changes that may include a brain tumor in the differential diagnosis, the physician is obliged to think of a possible organic cause of such symptoms, one of them being a neoplasm [1] [8]. For further testing, MR spectroscopy, functional MRI (fMRI), positron emission tomography (PET), or single-photon emission computed tomography (SPECT) imaging may be used [1].

Treatment for a frontal lobe neoplasm depends on several factors, including the type, size, and location of the tumor, as well as the patient's overall health. Options may include surgery to remove the tumor, radiation therapy to destroy cancer cells, and chemotherapy to target cancerous growths. In some cases, a combination of these treatments may be used. The goal is to remove or reduce the tumor while preserving as much brain function as possible.

The prognosis for a patient with a frontal lobe neoplasm varies based on the tumor's characteristics and the effectiveness of treatment. Benign tumors generally have a better prognosis than malignant ones. Early detection and treatment can improve outcomes, but some patients may experience long-term effects on cognitive and motor functions. Regular follow-up care is essential to monitor for any recurrence or progression of the disease.

The exact cause of frontal lobe neoplasms is not well understood. However, certain risk factors have been identified, including genetic predispositions, exposure to radiation, and a history of certain hereditary syndromes. In many cases, the development of these tumors is sporadic, meaning they occur without a clear cause.

Frontal lobe neoplasms are relatively rare compared to other types of brain tumors. They can occur at any age but are more commonly diagnosed in adults. The incidence of brain tumors, in general, is slightly higher in males than in females. The specific epidemiological patterns can vary depending on the type of tumor.

The pathophysiology of a frontal lobe neoplasm involves the abnormal growth of cells within the frontal lobe. This growth can disrupt normal brain function by compressing surrounding tissues, altering blood flow, and affecting neural pathways. The specific effects depend on the tumor's location and size, as well as its biological behavior.

Currently, there are no specific measures to prevent frontal lobe neoplasms. However, reducing exposure to known risk factors, such as radiation, may help lower the risk. Maintaining a healthy lifestyle and regular medical check-ups can aid in early detection and management of potential health issues.

Frontal lobe neoplasms are tumors located in the frontal lobe of the brain, affecting cognitive and motor functions. Symptoms can include personality changes, speech difficulties, and seizures. Diagnosis involves neurological exams and imaging studies, while treatment options include surgery, radiation, and chemotherapy. Prognosis varies based on tumor type and treatment success, with early detection being crucial for better outcomes.

If you or a loved one is experiencing symptoms such as changes in personality, difficulty with speech, or seizures, it is important to seek medical evaluation. A healthcare provider can perform the necessary tests to determine if a frontal lobe neoplasm or another condition is present. Understanding the potential symptoms and treatment options can help in managing the condition effectively.

1. Madhusoodanan S, Ting MB, Farah T, Ugur U. Psychiatric aspects of brain tumors: A review. World J Psychiatry. 2015;5(3):273-285.
2. Filley CM, Kleinschmidt-DeMasters BK. Neurobehavioral presentations of brain neoplasms. West J Med. 1995;163:19–25.
3. Arifin MZ, Yudoyono F, Setiawan C, Sidabutar R, Sutiono AB, Faried A. Comprehensive management of frontal and cerebellar tumor patients with personality changes and suicidal tendencies. Surg Neurol Int.. 2014;5:174.
4. Kopp B, Rösser N, Tabeling S, et al. Performance on the Frontal Assessment Battery is sensitive to frontal lobe damage in stroke patients. BMC Neurol. 2013;13:179.
5. Murphy P, Shallice T, Robinson G, et al. Impairments in proverb interpretation following focal frontal lobe lesions. Neuropsychologia. 2013;51:2075–2086.
6. Yakhmi S, Sidhu BS, Kaur J, Kaur A. Diagnosis of frontal meningioma presenting with psychiatric symptoms. Indian J Psychiatry. 2015;57(1):91-93.
7. Butler C, Zeman AZ. Neurological syndromes which can be mistaken for psychiatric conditions. J Neurol Neurosurg Psychiatry. 2005;76(Suppl 1):i31–8.
8. Albon E, Tsourapas A, Frew E, et al. Structural neuroimaging in psychosis: a systematic review and economic evaluation. Health Technol Assess. 2008;12:iii–iv, ix-163